EUVIMEDEUVIMED entdecken
Open Access

A wearable spatiotemporal controllable ultrasonic device with amyloid-β disaggregation for continuous Alzheimer’s disease therapy

Faxing Zou iD, Yibiao Liu iD, Yong Luo iD, Tailin Xu iD

Science Advances · 2025-08 · 11 (31)

DOI: 10.1126/sciadv.adw1732 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025-08. Verfasst von Faxing Zou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Study (IAS), Shenzhen University, Shenzhen, Guangdong 518060, People's Republic of China. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Wearable Electronic Devices, Ultrasonic Therapy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rising prevalence of Alzheimer’s disease (AD) due to an aging population has made the search for effective treatments more urgent than ever. Previous studies have demonstrated that continuous ultrasound can depolymerize amyloid proteins, offering potential relief from AD. In this study, we present a portable, fully integrated wearable ultrasound system designed to promote amyloid protein depolymerization. The system comprises a flexible honeycomb ultrasonic array patch, a flexible printed circuit, and an interactive terminal control system to facilitate the treatment process. Our results demonstrate that the system effectively reduces amyloid proteins in the brain, improves cognitive function in a familial Alzheimer’s disease (FAD) mouse model, enhances microglial phagocytosis of amyloid-β plaques, and shifts microglia polarization from M1 to M2. These changes contribute to a mitigated inflammatory environment in the brain. This innovative approach may pave the way for noninvasive, personalized treatments for AD, potentially transforming therapeutic strategies in neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesWearable Electronic DevicesUltrasonic TherapyProtein AggregatesAnimalsMiceDisease Models, AnimalMicrogliaHumansBrainPlaque, AmyloidMice, Transgenic

Substanzen

Amyloid beta-PeptidesProtein Aggregates

Autor:innen und Institutionen

  • Institute for Advanced Study (IAS), Shenzhen University, Shenzhen, Guangdong 518060, People's Republic of China.
  • Longgang Central Hospital of Shenzhen, Shenzhen 518116, People's Republic of China.

ORCID-Profile: Faxing Zou, Yibiao Liu, Yong Luo, Tailin Xu

Zitieren

APA

Zou, F., Liu, Y., Luo, Y., & Xu, T. (2025). A wearable spatiotemporal controllable ultrasonic device with amyloid-β disaggregation for continuous Alzheimer’s disease therapy. Science Advances, 11(31). https://doi.org/10.1126/sciadv.adw1732

Vancouver

Zou F, Liu Y, Luo Y, Xu T. A wearable spatiotemporal controllable ultrasonic device with amyloid-β disaggregation for continuous Alzheimer’s disease therapy. Science Advances. 2025;11(31). doi:10.1126/sciadv.adw1732

BibTeX
@article{Zou2025,
  author = {Zou, Faxing and Liu, Yibiao and Luo, Yong and Xu, Tailin},
  title = {A wearable spatiotemporal controllable ultrasonic device with amyloid-β disaggregation for continuous Alzheimer’s disease therapy},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {31},
  doi = {10.1126/sciadv.adw1732}
}
Kostenlos starten →